John Tanner has joined RNA Capital Advisors’ growing healthcare practice as Director. Mr. Tanner will focus on providing a greater breadth and depth of commercial and decision-support services to our healthcare, life science, technology and capital market clients.
Mr. Tanner brings over 20 years of experience in management consulting at top-tier strategy consulting firms and in senior-level executive roles at major medical device and diagnostics companies. He has deep strategic, commercial, and financial expertise, having led in-depth consulting engagements at over 60 corporate clients. Previously, he served as a Vice President and Senior Leadership Team executive at Edwards Lifesciences, where he held positions of increasing responsibility in Corporate Strategy, Strategic Marketing, Therapy Development, Product Marketing, and Sales Management, in both Global and US-focused roles.
Prior to joining RNA, John was the Vice President of Strategic Marketing for a genomic oncology diagnostic start-up. He has held strategy consulting positions at L.E.K. Consulting, Mitchell Madison Group, and Mitral Consulting. Mr. Tanner earned an M.B.A. in Analytic Finance from the University of Chicago with high honors, where he also received the Ryerson-Tull Prize for Management Excellence.
Sam Renwick, founding partner of RNA, said, “Our clients usually want help beyond assessing the value of their firm or of a market opportunity. They want help devising strategies to capitalize on those opportunities. Adding John to our team is a natural extension that will allow us to offer even more strategic and commercial guidance to client company leadership teams.”
John Tanner commented, “RNA Advisors has experienced rapid growth in the past several years by setting the standard for excellence in market assessment, analytics, and valuation in our core industries. We now bring that same standard to developing market-driven strategies and helping to make them commercial reality. I am proud to lead RNA’s strategic consulting practice focused on unlocking the full potential of our clients’ opportunities.”
About RNA Capital Advisors
RNA provides a unique blend of evidence-based strategy consulting and advanced financial modeling and valuation analytics to help our healthcare, life science and technology clients optimize outcomes for important issues. Better decisions and opinions come from credible, consistent, and evidenced-based perspectives supported by the analytic tools that help identify potential and mitigate risk. We help our clients through buy-side and sell-side support, internal strategic decision support and independent opinion services.
Contacts
RNA Capital Advisors
Sam Renwick
(925) 940-0259
sam.renwick@rnaadvisors.com
John Tanner
(949) 293-9569
john.tanner@rnaadvisors.com
